Hamed I. Ali

1.9k citations

60 papers · 1.6k indexed · h-index 27

Organic Chemistry top 2%
Molecular Biology
Pharmacology top 5%
Computational Theory and Mathematics top 5%
Oncology

Co-authors: Manal M. Anwar Kamelia M. Amin Tomohisa Nagamatsu Omaima M. Abdelhafez A. M. Soliman Mohamed M. Abdalla Eiichi Akaho Neama A. Mohamed
Topics: Synthesis and biological activity (22 papers)Synthesis of Organic Compounds (8 papers)Cancer therapeutics and mechanisms (7 papers)
Cited by: Organic Chemistry Toxicology Pharmacology
Journals: Scientific Reports International Journal of Molecular Sciences Journal of Medicinal Chemistry
Partner nations: Egypt United States Japan

In The Last Decade

Hamed I. Ali

58 papers receiving 1.5k citations

Peers

Countries citing papers authored by Hamed I. Ali

Since Specialization

Citations

This map shows the geographic impact of Hamed I. Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamed I. Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamed I. Ali more than expected).

Fields of papers citing papers by Hamed I. Ali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamed I. Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamed I. Ali. The network helps show where Hamed I. Ali may publish in the future.

Co-authorship network of co-authors of Hamed I. Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Hamed I. Ali. A scholar is included among the top collaborators of Hamed I. Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamed I. Ali. Hamed I. Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Breaking barriers: Medicinal chemistry strategies and advanced in-silico approaches for overcoming the BBB and enhancing CNS penetration 2025 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),Khaled A. M. Abouzid,Hamed I. Ali	0
2	Design, novel one-pot green synthesis, and biological evaluation of pyrazolopyridine-congeners selectively targeting HER2+ breast cancer 2025 ·Bioorganic Chemistry ·(unknown),Heba Abdelrasheed Allam,(unknown),Ishaq Khan,Tamer E. Fandy,(unknown),Zakaria Y. Abd Elmageed,Amgad Albohy,Hamed I. Ali,Samy Mohamady	0
3	Design, synthesis, and antitumor efficacy of novel 5-deazaflavin derivatives backed by kinase screening, docking, and ADME studies 2023 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·(unknown),Mosaad S. Mohamed,(unknown),Mohamed A. Elsawy,(unknown),Noriyuki Ashida,Ashraf N. Abdalla,(unknown),Tomohisa Nagamatsu,Hamed I. Ali	4
4	In-Situ Implant Formulation of Laurate and Myristate Prodrugs of Dolutegravir for Ultra-Long Delivery 2022 ·Journal of Pharmaceutical Sciences ·Tahir Khuroo,Eman M. Mohamed,Sathish Dharani,(unknown),Mohammad T. H. Nutan,Dai Lu,Hamed I. Ali,Mansoor A. Khan,Ziyaur Rahman	4
5	In-use stability assessment of FDA approved metformin immediate release and extended release products for N-Nitrosodimethylamine and dissolution quality attributes 2022 ·International Journal of Pharmaceutics ·Sathish Dharani,Eman M. Mohamed,Tahir Khuroo,Hamed I. Ali,Indra K. Reddy,Ziyaur Rahman,Mansoor A. Khan	14
6	Targeting CDC7 sensitizes resistance melanoma cells to BRAFV600E-specific inhibitor by blocking the CDC7/MCM2-7 pathway 2019 ·Scientific Reports ·(unknown),Hamdy Ali,(unknown),Rania M. Abdelsalam,Mourad Zerfaoui,Hamed I. Ali,(unknown),Sanaa A. Kenawy,Emad Kandil,Zakaria Y. Abd Elmageed	21
7	Structural-based design, synthesis, and antitumor activity of novel alloxazine analogues with potential selective kinase inhibition 2018 ·European Journal of Medicinal Chemistry ·(unknown),Ahmed M. Gouda,Hamdy Ali,(unknown),(unknown),Ashraf N. Abdalla,Juan J. Bustamante,Zakaria Y. Abd Elmageed,Hamed I. Ali	21
8	Dysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients 2018 ·Scientific Reports ·Hamdy Ali,(unknown),Andrew B. Sholl,(unknown),Juan J. Bustamante,Hamed I. Ali,Johng S. Rhim,Gagan Deep,Jinfeng Zhang,Zakaria Y. Abd Elmageed	26
9	Synthesis and molecular docking study of new benzofuran and furo[3,2- g ]chromone-based cytotoxic agents against breast cancer and p38α MAP kinase inhibitors 2018 ·Bioorganic Chemistry ·Kamelia M. Amin,Yasmin M. Syam,Manal M. Anwar,Hamed I. Ali,(unknown),(unknown)	58
10	Part II: New candidates of pyrazole-benzimidazole conjugates as checkpoint kinase 2 (Chk2) inhibitors 2017 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),Hamed I. Ali,Samia A. Shouman,Yasmin M. Attia,Mamdouh M. Ali,Abeer E. Mahmoud,(unknown),(unknown),Ashraf A. Tabll,Reem El‐Shenawy,Yasmine S. El,(unknown),Hoda I. El Diwani	26
11	Synthesis and molecular docking studies of new furochromone derivatives as p38α MAPK inhibitors targeting human breast cancer MCF-7 cells 2017 ·Bioorganic & Medicinal Chemistry ·Kamelia M. Amin,Yasmin M. Syam,Manal M. Anwar,Hamed I. Ali,(unknown),(unknown)	22
12	The plasticizer BBP selectively inhibits epigenetic regulator sirtuins 2015 ·Toxicology ·Jian Zhang,Hamed I. Ali,Yudhishtar S. Bedi,Mahua Choudhury	17
13	Synthesis, Docking and Biological Activities of Novel Hybrids Celecoxib and Anthraquinone Analogs as Potent Cytotoxic Agents 2014 ·International Journal of Molecular Sciences ·Maha S. Almutairi,Gehan A. Hegazy,Mogedda E. Haiba,Hamed I. Ali,Nagy M. Khalifa,A. M. Soliman	12
14	Synthesis, evaluation and molecular docking studies for the anti-inflammatory activity of novel 8-substituted- 7-benzoyloxy-4-methyl-6-nitrocoumarin derivatives 2014 ·African Journal of Pharmacy and Pharmacology ·Radwan El‐Haggar,(unknown),Tamer Nasr,Hamed I. Ali,A. Goudah,(unknown)	3
15	SN-38-Cyclodextrin Complexation and Its Influence on the Solubility, Stability, and In Vitro Anticancer Activity Against Ovarian Cancer 2014 ·AAPS PharmSciTech ·Kiran Kumar Vangara,Hamed I. Ali,Dai Lu,Jingbo Louise Liu,Srikanth Kolluru,Srinath Palakurthi	32
16	Reduction of Lipophilicity at the Lipophilic Domain of RXR Agonists Enables Production of Subtype Preference: RXRα‐Preferential Agonist Possessing a Sulfonamide Moiety 2007 ·ChemMedChem ·(unknown),Atsushi Takano,(unknown),(unknown),Nobuyasu Matsuura,Makoto Makishima,Hamed I. Ali,Eiichi Akaho,Akihiro Tai,Kenji Sasaki,Hiroki Kakuta	19
17	Antitumor studies. Part 3: Design, synthesis, antitumor activity, and molecular docking study of novel 2-methylthio-, 2-amino-, and 2-(N-substituted amino)-10-alkyl-2-deoxo-5-deazaflavins 2007 ·Bioorganic & Medicinal Chemistry ·Hamed I. Ali,Noriyuki Ashida,Tomohisa Nagamatsu	29
18	Antitumor studies – Part 2: Structure–activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase 2007 ·European Journal of Medicinal Chemistry ·Hamed I. Ali,(unknown),Eiichi Akaho,Munetaka Kunishima,Y. Kawashima,Takehiro Yamagishi,(unknown),Tomohisa Nagamatsu	28
19	Analgesic agents without gastric damage: Design and synthesis of structurally simple benzenesulfonanilide-type cyclooxygenase-1-selective inhibitors 2006 ·Bioorganic & Medicinal Chemistry ·Xiaoxia Zheng,Hiroyuki Oda,(unknown),Yukio Sugimoto,Akihiro Tai,Eiichi Akaho,Hamed I. Ali,Toshiyuki Oshiki,Hiroki Kakuta,Kenji Sasaki	30
20	Evaluation of selected Sudanese medicinal plants for their in vitro activity against hemoflagellates, selected bacteria, HIV-1-RT and tyrosine kinase inhibitory, and for cytotoxicity 2002 ·Journal of Ethnopharmacology ·Hamed I. Ali,Gabriele M. König,Sami A. Khalid,Anthony D. Wright,Ronald Kaminsky	81

About Hamed I. Ali

Hamed I. Ali is a scholar working on Toxicology, Organic Chemistry and Pharmacology, having authored 60 papers that have together received 1.6k indexed citations. Recurring topics across this work include Synthesis and biological activity (22 papers), Synthesis of Organic Compounds (8 papers) and Cancer therapeutics and mechanisms (7 papers). The work is most often cited by research in Organic Chemistry (786 citations), Toxicology (93 citations) and Pharmacology (323 citations). Hamed I. Ali has collaborated with scholars based in Egypt, United States and Japan. Frequent co-authors include Manal M. Anwar, Kamelia M. Amin, Tomohisa Nagamatsu, Omaima M. Abdelhafez, A. M. Soliman, Mohamed M. Abdalla, Eiichi Akaho, Neama A. Mohamed, Noriyuki Ashida and M. M. KAMEL. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact